Abstract
Bacillus subtilis is currently used as an oral probiotic. We examined two commercial B. subtilis probiotic preparations, Enterogermina and Biosubtyl. Surprisingly, physiological and genetic characterization of the bacteria contained in each of these preparations has shown that neither contains B. subtilis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Bacillus / classification
-
Bacillus / drug effects
-
Bacillus / genetics
-
Bacillus / physiology*
-
Bacillus subtilis / classification
-
Bacillus subtilis / drug effects
-
Bacillus subtilis / growth & development
-
Bacillus subtilis / physiology*
-
Drug Resistance, Microbial
-
Polymerase Chain Reaction
-
Probiotics*
-
RNA, Ribosomal, 16S / genetics
-
Sequence Analysis, DNA
-
Spores, Bacterial / physiology
Substances
-
Anti-Bacterial Agents
-
RNA, Ribosomal, 16S
Associated data
-
GENBANK/AF142574
-
GENBANK/AF142575
-
GENBANK/AF142576
-
GENBANK/AF142577